Bone Marrow Derived-Mesenchymal Stem Cell Improves Diabetes-Associated Fatty Liver via Mitochondria Transformation in Mice

A type 2 diabetes mellitus (T2DM) model was established through 28-week high-fat diet feeding resulting in T2DM-associated non-alcoholic fatty liver disease, followed by the injection of bone marrow MSCs.